Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
So | QLife Holding AB: The Letter of Intent with Hipro Biotechnology Co., Ltd. regarding reverse takeover has been extended | 21 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") announces an extension of the Letter of Intent regarding a potential reverse takeover (the "Transaction") with Hipro Biotechnology Co., Ltd. ("Hipro"). The... ► Artikel lesen | |
22.09. | Qlife Holding AB announces the outcome of the exercise of warrants series TO 6 | 1 | Cision News | ||
15.09. | QLife Holding AB: Qlife announces additional product line and progresses two new tests into clinical trials | 93 | GlobeNewswire (Europe) | Qlife, a first mover in clinical-grade home diagnostics, and its partner Hipro Biotechnology are advancing two additional biomarker tests-nt-proBNP and potassium-into clinical trials targeting Congestive... ► Artikel lesen | |
27.08. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q2, April to June 2025 | 102 | GlobeNewswire (Europe) | Towards a merger with a vision
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary - second quarter 2025
Revenue... ► Artikel lesen | |
QLIFE Aktie jetzt für 0€ handeln | |||||
27.08. | QLife Holding AB: Progress update on the reverse takeover process between Qlife and Hipro | 113 | GlobeNewswire (Europe) | Gothenburg, Sweden - Qlife Holding AB ("Qlife" or the "Company") and Hipro Biotechnology Co., Ltd. ("Hipro") remain fully committed to completing the transaction announced in the Letter of Intent signed... ► Artikel lesen | |
21.08. | Qlife Holding AB increases existing credit facility and extends the maturity date | 1 | Cision News | ||
21.08. | QLIFE HOLDING AB: Qlife together with Birmingham Women's and Children's NHS Foundation Trust achieve positive results for its rare disease self-test PHE product | 2 | Cision News | ||
09.07. | QLIFE HOLDING AB: Qlife resolves to carry out a directed set-off issue of approximately SEK 2.47 million in accordance with previously announced credit facility agreement | 1 | Cision News | ||
05.06. | Qlife Holding AB receives observation status | 208 | GlobeNewswire | Today, June 5, 2025, Qlife Holding AB (the "Company") issued a press release with information that it has entered into a letter of intent for a reverse takeover of Hipro Biotechnology Co., Ltd.,... ► Artikel lesen | |
05.06. | QLife Holding AB: Qlife enters letter of intent with Hipro Biotechnology Co., Ltd. to join forces through a reverse takeover | 200 | GlobeNewswire (Europe) | Qlife Holding AB ("Qlife" or the "Company") has entered into a non-binding letter of intent ("Letter of Intent") with Hipro Biotechnology Co., Ltd., registration no. 91130100794182204D, ("Hipro") regarding... ► Artikel lesen | |
28.05. | QLife Holding AB: Bulletin from the annual general meeting 2025 of Qlife Holding AB | 119 | GlobeNewswire (Europe) | Qlife Holding AB held its annual general meeting on 28 May 2025. At the meeting, the following resolutions were made.
The English text is an unofficial translation. In case of any discrepancies between... ► Artikel lesen | |
20.05. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q1, January to March 2025 | 225 | GlobeNewswire (Europe) | Progress on all levels
The full report is attached and can also be found here: https://qlifeholding.com/en/investors/finansiella-rapporter
Financial summary - first quarter 2025
Revenue in the... ► Artikel lesen | |
07.05. | Qlife Holding AB publishes Annual Report for 2024 | 1 | Cision News | ||
10.04. | QLIFE HOLDING AB: Qlife announces strategic roadmap update | 2 | Cision News | ||
25.03. | QLife Holding AB: Qlife announces that it has received approval from UK authorities to initiate a clinical trial in the UK | 192 | GlobeNewswire (Europe) | The Egoo Phe System, developed to measure phenylalanine (Phe) levels associated with the PKU condition, is now entering its final phase ahead of initial registration in the UK and submission to a Notified... ► Artikel lesen | |
21.03. | QLife Holding AB: Bulletin from the extraordinary general meeting in Qlife Holding AB on 21 March 2025 | 246 | GlobeNewswire (Europe) | Today, on 21 March 2025, an extraordinary general meeting was held in Qlife Holding AB. A summary of the adopted resolutions follows below.
Election and remuneration of the board of directors
The... ► Artikel lesen | |
04.03. | The observation status for Qlife Holding AB is removed | 198 | GlobeNewswire | On February 13, 2024, Qlife Holding AB (the "Company") was given observation status with reference to material adverse uncertainty in respect of the issuer's financial position.
On February 26... ► Artikel lesen | |
26.02. | QLife Holding AB: Qlife announces outcome in rights issue | 268 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
17.02. | QLife Holding AB: Qlife announces the launch of Egoo.AI and the start of sales for the Women's Health platform | 316 | GlobeNewswire (Europe) | Qlife is proud to announce a major expansion of Egoo.Health with the launch of Egoo.AI, an advanced AI-driven platform designed to provide users with personalized insights based on biomarker test results... ► Artikel lesen | |
06.02. | QLife Holding AB: QLIFE HOLDING AB, Interim Report Q4, October to December 2024 | 211 | GlobeNewswire (Europe) | Transition to a commercial business
Financial summary - fourth quarter 2024
Revenue in the period amounted to kSEK 50 (30).
EBITDA for the period amounted to kSEK -7,721 (-86,903), and net loss... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MOUNTAIN VALLEY MD | 0,014 | +40,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
BRIGHTSPRING HEALTH SERVICES | 28,360 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance |
LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 48,260 | +1,30 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
GERRESHEIMER | 37,680 | -0,74 % | Was ist los bei Gerresheimer? Almonty Industries und Rheinmetall boomen wieder! | In unsicheren Zeiten rücken Unternehmen in den Fokus, die das Rückgrat unserer kritischen Infrastrukturen bilden. Ihre Fähigkeit, widerstandsfähige und transparente Lieferketten für essentielle Güter... ► Artikel lesen | |
GENEDX | 118,32 | 0,00 % | GeneDx announces first genomic newborn screening initiative | ||
FRESENIUS | 47,090 | -0,15 % | ROUNDUP/Aktien Frankfurt Schluss: Dax setzt wieder zurück - Richtungssuche | FRANKFURT (dpa-AFX) - Nach den leichten Gewinnen am Vortag hat der Dax am Donnerstag wieder den Rückwärtsgang eingelegt. Als Belastung für die hiesigen Börsen erwiesen sich zeitweise vor allem die... ► Artikel lesen | |
UNITEDHEALTH | 310,45 | +1,27 % | 3 Charts in 3x33 Sekunden - Heute mit NVIDIA, UnitedHealth Group und Palladium | Willkommen zu '3 Charts in 33 Sekunden'! Jörg Scherer stellt uns drei Charts vor, die er aktuell ganz besonders unter die Lupe nimmt. Welche Ziele oder Signale jetzt wichtig sind, erfahren Sie im Video!... ► Artikel lesen | |
NUTEX HEALTH | 107,88 | 0,00 % | Nutex Health, Inc.: Nutex Health Announces The Appointment Of Wesley Bamburg As Its New Chief Operating Officer | HOUSTON, Sept. 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 45,620 | +0,11 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 16,620 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors | ORANGE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2026 product portfolio, offering 68... ► Artikel lesen | |
KESTRA MEDICAL TECHNOLOGIES | 24,820 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports First Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for... ► Artikel lesen | |
CARL ZEISS MEDITEC | 45,440 | +0,44 % | Carl Zeiss Meditec schockt am Montag: Droht der Totalabsturz - Insider schlagen Alarm! | ||
KINDLY MD | 1,130 | 0,00 % | KindlyMD, Inc: KindlyMD Secures $200 Million Credit Facility from Two Prime and Completes Convertible Note Redemption | Provides Flexibility to Pursue Long-Term Growth Strategy While Preserving Bitcoin Holdings and Strengthening the Company's Balance Sheet SALT LAKE CITY, UT / ACCESS Newswire / October 3, 2025 / KindlyMD... ► Artikel lesen | |
CLEARPOINT NEURO | 27,390 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System | New Product Category Will Enable Added Flexibility to Support Commercial Launches of Cell and Gene Therapy SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 1, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT)... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 35,990 | 0,00 % | PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance | SAN JOSE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |